United Kingdom· GB-APID-44167411000001106
Carvykti 3.2million-100million cells dispersion for infusion bags
A ciltacabtagene autoleucel product containing ciltacabtagene autoleucel, registered in United Kingdom by Janssen-Cilag Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Ciltacabtagene autoleucel is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XL05 (ciltacabtagene autoleucel), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Ciltacabtagene autoleucel · ATC L01XL05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ciltacabtagene autoleucel
- Manufacturer
- Janssen-Cilag Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XL05
- ATC class
- Ciltacabtagene autoleucel
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05012674089095
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciltacabtagene autoleucel in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCARVYKTIJanssen Biotech, Inc.
- SwitzerlandCarvyktiJanssen-Cilag AG
- CzechiaCARVYKTIJanssen-Cilag International N.V., Beerse
- SpainCARVYKTI 3,2 × 10e6 - 1 × 10e8 CELULAS DISPERSION PARA PERFUSIONJanssen-Cilag International N.V
- FinlandCARVYKTIJanssen-Cilag International NV
- FranceCARVYKTI 3,2 x 1 000 000 - 1 x 100 000 000 cellules, dispersion pour perfusionJANSSEN CILAG INTERNATIONAL NV
- BelgiumCarvykti 3,2 x 10*6-1,0 x 10*8 cellsJanssen-Cilag International
- IcelandCarvyktiJanssen-Cilag International NV*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Carvykti
- Liechtenstein · Carvykti
- Norway · Carvykti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/326e1b9c-d163-41b4-aaee-a08fa59ddc4c GET /v1/drugs/326e1b9c-d163-41b4-aaee-a08fa59ddc4c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44167411000001106",
"desc": "Carvykti 3.2million-100million cells dispersion for infusion bags (Janssen-Cilag Ltd)",
"form": "Dispersion for infusion",
"vpid": "44168711000001104",
"source": "dmd",
"vtm_id": "44168311000001103",
"strength": null,
"substance": "Ciltacabtagene autoleucel",
"ingredient": "Ciltacabtagene autoleucel",
"supplier_code": "2422501000001106"
}See everything about ciltacabtagene autoleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.